99 related articles for article (PubMed ID: 11746356)
41. The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease.
Mason I
Pharm Acta Helv; 2000 Mar; 74(2-3):261-4. PubMed ID: 10812967
[TBL] [Abstract][Full Text] [Related]
42. The GDNF family ligands and receptors - implications for neural development.
Baloh RH; Enomoto H; Johnson EM; Milbrandt J
Curr Opin Neurobiol; 2000 Feb; 10(1):103-10. PubMed ID: 10679429
[TBL] [Abstract][Full Text] [Related]
43. Signal transduction by the receptor tyrosine kinase Ret.
van Weering DH; Bos JL
Recent Results Cancer Res; 1998; 154():271-81. PubMed ID: 10027007
[TBL] [Abstract][Full Text] [Related]
44. GDNF family neurotrophic factor signaling: four masters, one servant?
Airaksinen MS; Titievsky A; Saarma M
Mol Cell Neurosci; 1999 May; 13(5):313-25. PubMed ID: 10356294
[No Abstract] [Full Text] [Related]
45. RET-independent signaling by GDNF ligands and GFRα receptors.
Ibáñez CF; Paratcha G; Ledda F
Cell Tissue Res; 2020 Oct; 382(1):71-82. PubMed ID: 32737575
[TBL] [Abstract][Full Text] [Related]
46. The GDNF/RET signaling pathway and human diseases.
Takahashi M
Cytokine Growth Factor Rev; 2001 Dec; 12(4):361-73. PubMed ID: 11544105
[TBL] [Abstract][Full Text] [Related]
47. The GDNF-RET signalling partnership.
Robertson K; Mason I
Trends Genet; 1997 Jan; 13(1):1-3. PubMed ID: 9009838
[No Abstract] [Full Text] [Related]
48. III. Role Of the RET signal transduction pathway in development of the mammalian enteric nervous system.
Pachnis V; Durbec P; Taraviras S; Grigoriou M; Natarajan D
Am J Physiol; 1998 Aug; 275(2):G183-6. PubMed ID: 9688643
[TBL] [Abstract][Full Text] [Related]
49. The GDNF family: signalling, biological functions and therapeutic value.
Airaksinen MS; Saarma M
Nat Rev Neurosci; 2002 May; 3(5):383-94. PubMed ID: 11988777
[TBL] [Abstract][Full Text] [Related]
50. The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers.
Li Q; Cao Z; Zhao S
Int J Med Sci; 2022; 19(4):659-668. PubMed ID: 35582425
[TBL] [Abstract][Full Text] [Related]
51. RET and neuroendocrine tumors.
Ichihara M; Murakumo Y; Takahashi M
Cancer Lett; 2004 Feb; 204(2):197-211. PubMed ID: 15013219
[TBL] [Abstract][Full Text] [Related]
52. [The GDNF family: from neurotrophic factors to oncogenesis].
Poteriaev DA; Saarma M
Mol Biol (Mosk); 2001; 35(2):309-20. PubMed ID: 11357413
[TBL] [Abstract][Full Text] [Related]
53. The coming of age of the GDNF family and its receptors: gene delivery in a rat Parkinson model may have clinical implications.
Olson L
Trends Neurosci; 1997 Jul; 20(7):277-9. PubMed ID: 9223215
[No Abstract] [Full Text] [Related]
54. Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.
Mahato AK; Sidorova YA
Cell Tissue Res; 2020 Oct; 382(1):147-160. PubMed ID: 32556722
[TBL] [Abstract][Full Text] [Related]
55. Evolution of the GDNF family ligands and receptors.
Airaksinen MS; Holm L; Hätinen T
Brain Behav Evol; 2006; 68(3):181-90. PubMed ID: 16912471
[TBL] [Abstract][Full Text] [Related]
56. [Molecular basis of Hirschsprung disease].
Inoue M; Okada A
Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
[TBL] [Abstract][Full Text] [Related]
57. Intracellular RET signaling pathways activated by GDNF.
Kawai K; Takahashi M
Cell Tissue Res; 2020 Oct; 382(1):113-123. PubMed ID: 32816064
[TBL] [Abstract][Full Text] [Related]
58. GDNF in a bind with known orphan: accessory implicated in new twist.
Lindsay RM; Yancopoulos GD
Neuron; 1996 Oct; 17(4):571-4. PubMed ID: 8893014
[No Abstract] [Full Text] [Related]
59. The GDNF receptor: recent progress and unanswered questions.
Mason I
Mol Cell Neurosci; 1996; 8(2-3):112-9. PubMed ID: 8918828
[No Abstract] [Full Text] [Related]
60. The bound leading the bound: target-derived receptors act as guidance cues.
Crone SA; Lee KF
Neuron; 2002 Oct; 36(3):333-5. PubMed ID: 12408835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
